MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Industry news

Related news

Latest News

BD Diagnostics Launches the BD Protect(TM) Infection Surveillance and Prevention Software Portfolio
Nanosphere Verigene(R) SP Respiratory Virus Panel Categorized as Moderate Complexity by FDA
Sun Pharma announces USFDA approval for generic Prometh
Giant Step Forward for AsepticSure(TM)
FIND, the Earth Institute and Uganda's Health Ministry collaborate to improve malaria reporting
PolyMedix Presents PMX-30063 Antibiotic Data at 8th World Congress on Trauma, Shock, Inflammation and Sepsis - TSIS 2010
Takara Bio to Enter into a Collaborative Research Agreement with University of Pennsylvania, Aiming for a Future Clinical Trial of HIV Gene Therapy
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter Fiscal Year 2010
NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
Amarillo Biosciences (AMAR) and Intas Pharmaceuticals Sign License and Supply Agreement to Use Oral Interferon to Treat Influenza in India and Nepal
More news... | RSS Feed...

Most Viewed

MediGene and Teva sign agreement to commercialize Veregen(TM) in Israel

Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to Develop and Commercialize microRNA Therapeutics Targeting miR-122

St. Jude Medical Expands Hospital Access to Wireless Fractional Flow Reserve Technology with New Agreement

FDA Announces Possible Safety Concern for HIV Drug Combination

Full-year accounts for 2009

ENANTA NOMINATES EDP-239 AS LEAD DEVELOPMENT CANDIDATE FOR NS5A HCV INHIBITOR PROGRAM

European CHMP adopts negative opinion on ceftobiprole

PARI Pharma's Altera Delivers Gilead's Cayston, Approved by the U.S. FDA for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa

Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nosocomial Pneumonia

Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us